These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 2473801

  • 1. Sodium butyrate enhances fetal globin gene expression in erythroid progenitors of patients with Hb SS and beta thalassemia.
    Perrine SP, Miller BA, Faller DV, Cohen RA, Vichinsky EP, Hurst D, Lubin BH, Papayannopoulou T.
    Blood; 1989 Jul; 74(1):454-9. PubMed ID: 2473801
    [Abstract] [Full Text] [Related]

  • 2. Butyric acid modulates developmental globin gene switching in man and sheep.
    Perrine SP, Swerdlow P, Faller DV, Qin G, Rudolph AM, Reczek J, Kan YW.
    Adv Exp Med Biol; 1989 Jul; 271():177-83. PubMed ID: 2484761
    [Abstract] [Full Text] [Related]

  • 3. Alterations in protein-DNA interactions in the gamma-globin gene promoter in response to butyrate therapy.
    Ikuta T, Kan YW, Swerdlow PS, Faller DV, Perrine SP.
    Blood; 1998 Oct 15; 92(8):2924-33. PubMed ID: 9763579
    [Abstract] [Full Text] [Related]

  • 4. Common haplotype dependency of high G gamma-globin gene expression and high Hb F levels in beta-thalassemia and sickle cell anemia patients.
    Labie D, Pagnier J, Lapoumeroulie C, Rouabhi F, Dunda-Belkhodja O, Chardin P, Beldjord C, Wajcman H, Fabry ME, Nagel RL.
    Proc Natl Acad Sci U S A; 1985 Apr 15; 82(7):2111-4. PubMed ID: 2580306
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of Rapamycin as Inducer of Hb F in Primary Erythroid Cultures from Sickle Cell Disease and β-Thalassemia Patients.
    Pecoraro A, Troia A, Calzolari R, Scazzone C, Rigano P, Martorana A, Sacco M, Maggio A, Di Marzo R.
    Hemoglobin; 2015 Apr 15; 39(4):225-9. PubMed ID: 26016899
    [Abstract] [Full Text] [Related]

  • 6. Interferon-gamma modulates fetal hemoglobin synthesis in sickle cell anemia and thalassemia.
    Miller BA, Olivieri N, Hope SM, Faller DV, Perrine SP.
    J Interferon Res; 1990 Aug 15; 10(4):357-66. PubMed ID: 1700029
    [Abstract] [Full Text] [Related]

  • 7. A short-term trial of butyrate to stimulate fetal-globin-gene expression in the beta-globin disorders.
    Perrine SP, Ginder GD, Faller DV, Dover GH, Ikuta T, Witkowska HE, Cai SP, Vichinsky EP, Olivieri NF.
    N Engl J Med; 1993 Jan 14; 328(2):81-6. PubMed ID: 7677966
    [Abstract] [Full Text] [Related]

  • 8. Differences in response to fetal hemoglobin induction therapy in beta-thalassemia and sickle cell disease.
    Fathallah H, Taher A, Bazarbachi A, Atweh GF.
    Blood Cells Mol Dis; 2009 Jan 14; 43(1):58-62. PubMed ID: 19346141
    [Abstract] [Full Text] [Related]

  • 9. Butyrate derivatives. New agents for stimulating fetal globin production in the beta-globin disorders.
    Perrine SP, Olivieri NF, Faller DV, Vichinsky EP, Dover GJ, Ginder GD.
    Am J Pediatr Hematol Oncol; 1994 Feb 14; 16(1):67-71. PubMed ID: 7508690
    [Abstract] [Full Text] [Related]

  • 10. Stimulation of fetal hemoglobin production by short chain fatty acids.
    Liakopoulou E, Blau CA, Li Q, Josephson B, Wolf JA, Fournarakis B, Raisys V, Dover G, Papayannopoulou T, Stamatoyannopoulos G.
    Blood; 1995 Oct 15; 86(8):3227-35. PubMed ID: 7579419
    [Abstract] [Full Text] [Related]

  • 11. Isobutyramide, an orally bioavailable butyrate analogue, stimulates fetal globin gene expression in vitro and in vivo.
    Perrine SP, Dover GH, Daftari P, Walsh CT, Jin Y, Mays A, Faller DV.
    Br J Haematol; 1994 Nov 15; 88(3):555-61. PubMed ID: 7529533
    [Abstract] [Full Text] [Related]

  • 12. Butyrate increases the efficiency of translation of gamma-globin mRNA.
    Weinberg RS, Ji X, Sutton M, Perrine S, Galperin Y, Li Q, Liebhaber SA, Stamatoyannopoulos G, Atweh GF.
    Blood; 2005 Feb 15; 105(4):1807-9. PubMed ID: 15479724
    [Abstract] [Full Text] [Related]

  • 13. Butyrate-induced reactivation of the fetal globin genes: a molecular treatment for the beta-hemoglobinopathies.
    Perrine SP, Faller DV.
    Experientia; 1993 Feb 15; 49(2):133-7. PubMed ID: 7680003
    [Abstract] [Full Text] [Related]

  • 14. Cellular and molecular effects of a pulse butyrate regimen and new inducers of globin gene expression and hematopoiesis.
    Ikuta T, Atweh G, Boosalis V, White GL, Da Fonseca S, Boosalis M, Faller DV, Perrine SP.
    Ann N Y Acad Sci; 1998 Jun 30; 850():87-99. PubMed ID: 9668531
    [Abstract] [Full Text] [Related]

  • 15. Intrinsic potential for high fetal hemoglobin production in a Druz family with beta-thalassemia is due to an unlinked genetic determinant.
    Oppenheim A, Yaari A, Rund D, Rachmilewitz EA, Nathan D, Wong C, Kazazian HH, Miller B.
    Hum Genet; 1990 Dec 30; 86(2):175-80. PubMed ID: 1702403
    [Abstract] [Full Text] [Related]

  • 16. The cellular basis for different fetal hemoglobin levels among sickle cell individuals with two, three, and four alpha-globin genes.
    Dover GJ, Chang VT, Boyer SH, Serjeant GR, Antonarakis S, Higgs DR.
    Blood; 1987 Jan 30; 69(1):341-4. PubMed ID: 2431731
    [Abstract] [Full Text] [Related]

  • 17. Butyrate in the treatment of sickle cell disease and beta-thalassemia.
    Faller DV, Perrine SP.
    Curr Opin Hematol; 1995 Mar 30; 2(2):109-17. PubMed ID: 9371980
    [Abstract] [Full Text] [Related]

  • 18. Stopping the biologic clock for globin gene switching.
    Perrine SP, Faller DV, Swerdlow P, Miller BA, Bank A, Sytkowski AJ, Reczek J, Rudolph AM, Kan YW.
    Ann N Y Acad Sci; 1990 Mar 30; 612():134-40. PubMed ID: 1705405
    [Abstract] [Full Text] [Related]

  • 19. The synthesis of fetal hemoglobin types in red blood cells and in BFU-E derived colonies from peripheral blood of patients with sickle cell anemia, beta+ - and delta beta-thalassemia, various forms of hereditary persistence of fetal hemoglobin, normal adults and newborn.
    Huisman TH, Efremov GD, Reese AL, Howard JS, Gravely ME, Harris HF, Wilson JB.
    Hemoglobin; 1979 Mar 30; 3(4):223-52. PubMed ID: 500369
    [Abstract] [Full Text] [Related]

  • 20. Hydroxyurea increases hemoglobin F levels and improves the effectiveness of erythropoiesis in beta-thalassemia/hemoglobin E disease.
    Fucharoen S, Siritanaratkul N, Winichagoon P, Chowthaworn J, Siriboon W, Muangsup W, Chaicharoen S, Poolsup N, Chindavijak B, Pootrakul P, Piankijagum A, Schechter AN, Rodgers GP.
    Blood; 1996 Feb 01; 87(3):887-92. PubMed ID: 8562958
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.